Updated May 30 at 5:25am
Biotechnology
56 results total, viewing 31 - 40
When the University of Rhode Island’s Department of Cell and Microbiology saw an opportunity to help address the needs of Rhode Island’s biotech and pharmaceutical companies and satisfy student interest, it ran with it. more
CVS Health Corp. pays among the highest taxes in the nation, according to WalletHub, which released its S&P 100 tax rates report on Wednesday. more
Tivorsan Pharmaceuticals Inc. has named James E. Connolly CEO. The biotechnology company, which focuses on treating Duchenne Muscular Dystrophy and other neuromuscular disorders, also said that Connolly will serve as a member of its board. more
Medtronic PLC, the world’s biggest maker of heart-rhythm devices, met third-quarter profit estimates as its newest products continue to take market share from rivals. more
Gov. Gina M. Raimondo visited Tech Collective, Rhode Island’s information technology and bioscience organization, on Feb. 22 for a roundtable discussion with business leaders about skills that matter. more
Mnemosyne Pharmaceuticals has changed its name to Luc Therapeutics and moved its headquarters from Providence to Cambridge. more
Medtronic PLC plans to consolidate its operations in Mansfield. Company spokesman Fernando Vivanco said Medtronic will consolidate its buildings from four to three. more
The University of Rhode Island has received five grants totaling $629,550 from The Champlin Foundations. more
The Providence Children’s Museum has received a $40,000 grant from the Amgen Foundation to support hands-on science, technology, engineering and math activities. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 Next »